SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

AstraZenecas reported Baxfendy sales have traders questioning how quickly the new aldosterone-inhibitor class can gain coverage and commercial traction, weighing on expectations for Mineralys planned launch. Some see the early sales as a normal reimbursement ramp for a chronic treatment, while others worry that a slow launch and competition could constrain lorundrostats sales potential.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of Voceryq, a competing treatment for recurrent respiratory papillomatosis, has put pressure on Precigens PAPZIMEOS and raised concerns about competition. Traders debate the threat to Precigens sales against its first-mover and full-approval advantages, while noting Voceryqs accelerated-approval status and commercialization hurdles.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is drawing attention after Piper Sandler lowered its price target, keeping a Neutral rating while pointing to concerns that networking growth may be peaking and valuations could compress. Traders are debating whether the selloff is justified or an overreaction, with bulls pointing to continued AI-infrastructure demand and bears focused on weak price action.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,617.445403. The last known price of Zebec Network is 0.00204055 USD and is down -0.09 over the last 24 hours. It is currently trading on 133 active market(s) with $10,537,951.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Traders are focused on reported MoneyGram connectivity and Zebecs broader payroll and payments expansion, viewing real-world adoption and potential token demand as bullish catalysts. Others remain skeptical, pointing to weak price follow-through and questioning whether business growth will translate into sustained ZBCN usage or buybacks.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 data for Amgens IMDELLTRAImfinzi combination in small-cell lung cancer is supporting bullish attention as shares reach a fresh high, with traders also focused on the upcoming earnings report and a Sjgrens disease readout. Put-heavy options activity is being debated as possible earnings hedging rather than a clear bearish bet, alongside call buying and momentum interest.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIMs attention is centered on its higher full-year outlook, which traders link to persistently strong container freight rates and demand, boosting expectations for earnings and dividends. The community is also debating whether Hapag-Lloyds acquisition can clear Israeli regulatory objections, with some favoring a sale and others preferring standalone cash generation and dividends.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a 52-week high ahead of the expected Q3 report has traders focused on BRIUMVIs sales momentum, while unconfirmed buyout speculation and call-heavy options activity add to the buzz. The community is split on whether the rally reflects earnings positioning and potential short covering or anticipation of a deal; no buyout has been confirmed.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons agreed sale of its Eagle Ford assets to Crescent is driving attention, following earlier speculation about asset divestitures and pressure to streamline the company after its Coterra merger. Traders are divided on whether the sale improves focus and capital allocation, with some questioning why the shares have not responded more strongly.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders react to a sharp tech-led Nasdaq selloff and falling futures, with worries about AI spending returns and disappointing tech results reinforcing bearish bets. Many are buying or holding SQQQ as a hedge, while others warn that the leveraged ETF can reverse quickly; separate Iran-deal chatter remains unverified and contested.

3M Co. is a technology company, which engages in manufacturing industrial, safety, and consumer products. It operates through the following segments: Safety and Industrial, Transportation and Electronics, Consumer, and Corporate. The Safety and Industrial segment consists of personal safety, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules. The Transportation and Electronics segment includes electronics, automotive and aerospace, commercial solutions, advanced materials, and transportation safety. The Consumer segment covers consumer healthcare, home care, home improvement, and stationery and office products, such as consumer bandages, braces, supports, respirators, cleaning products, retail abrasives, picture hanging, and consumer air quality solutions. The Corporate segment refers to special items and other corporate expenses. The company was founded by Henry S. Bryan, Hermon W. Cable, John Dwan, William A. McGonagle, and J. Danley Budd in 1902 and is headquartered in St. Paul, MN.

3M Co.

3Ms earnings beat and raised outlook, alongside its expanded Amazon data-center partnership, are driving attention. Bulls see the deal as a growth opportunity, while skeptics note that Amazons purchase threshold is conditional and call the rally overdone, with bearish traders discussing puts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BG Q3 Earnings Beat on Strong Soybean and Softseed Results

Bunge's Q3 earnings beat estimates as strong soybean and softseed processing boosted profits, while weaker segments weighed on results. The company maintained its 2026 earnings outlook.

Bunge Global Q3 2026 Earnings Call Transcript

Bunge Global (NYSE:BG) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Compared to Estimates, Bunge Global (BG) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Bunge Global (BG) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Bunge Global Q3 Net Income Surges; Backs 2026 Earnings Guidance

(RTTNews) - Bunge Global SA (BG), an agribusiness, food processing, and grain trading company, on Thursday reported a surge in net income for the third quarter of fiscal 2026...

Bunge Global (BG) Q3 Earnings and Revenues Beat Estimates

Bunge Global (BG) delivered earnings and revenue surprises of +4.49% and +3.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Bunge Reports Third Quarter 2026 Results

Bunge Global SA (NYSE: BG) today reported third quarter 2026 results. Q3 GAAP diluted EPS from continuing operations of $1.64 vs. $0.86 in the prior year; $2.56 vs. $2.27 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences Continued strong performance in...

Bunge Ready to Report Q3 Earnings: What's in Store for the Stock?

BG is set to report Q3 2026 earnings, with sales and profits expected to grow as the Viterra acquisition boosts processing capacity and global reach.

Bunge Global (BG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Bunge Global (BG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bunge World Food Day Volunteer Program Supports Food Security Around the World

Bunge Global SA (NYSE: BG), a premier agribusiness solutions company connecting farmers to consumers, today announced its annual World Food Day Global Volunteer Program, marking five years of community impact and collaboration. Throughout October, Bunge volunteers will join approximately 112 local...

Bunge Schedules Third Quarter 2026 Earnings Release and Conference Call

Bunge Global SA (NYSE: BG) will announce its results for the quarter ended Sept. 30, 2026, on Thursday, Oct. 29, 2026, prior to the market opening. Company management will also host a conference call at 7 a.m. Central Time to discuss the results. A slide presentation to accompany the discussion...

$BG Q3 &#39;26 Earnings Results &amp; Recap

Bunge maintained full-year 2026 adjusted EPS outlook at $9.25 to $9.75; Bunge expects 2026 adjusted annual effective tax rate of 23% to 25% and net interest expense of $640M.

Stocktwits

Bunge Ltd.

 Q3 '26 Earnings Results & Recap

Bunge maintained full-year 2026 adjusted EPS outlook at $9.25 to $9.75; Bunge expects 2026 adjusted annual effective tax rate of 23% to 25% and net interest expense of $640M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Bunge maintained full-year 2026 adjusted EPS outlook at $9.25 to $9.75; Bunge expects 2026 adjusted annual effective tax rate of 23% to 25% and net interest expense of $640M.

Bunge's 2026 net interest expense range was revised to $640M; cash used for operations was $2.3B amid working-capital changes, while Tropical Oils results were lower amid trade disruptions and commissioning costs.

Bunge's soybean and softseed adjusted Segment EBIT exceeded prior-year figures; Bunge advanced Viterra-related synergies and began new oilseed-line production, while adjusted FFO was $2.01B versus $1.18B.

Bunge Global SA engages in agribusiness including food and ingredients. It operates through the following segments: Agribusiness, Refined & Specialty Oils, Milling, Sugar & Bioenergy, and Corporate & Other. The Agribusiness segment is an integrated, global business principally involved in the purchase, storage, transportation, processing and sale of agricultural commodities and commodity products. The Refined & Specialty Oils segment includes businesses that sell vegetable oils and fats, including cooking oils, shortenings, specialty ingredients, and renewable diesel feedstocks. The Milling segment refers to the businesses that sell wheat flours, bakery mixes, and corn-based products. The Sugar & Bioenergy segment consists of results from the company’s previously owned 50% ownership interest in BP Bunge Bioenergia. The Corporate & Other segment focuses on the salaries and overhead for corporate functions that are not allocated to individual reporting segments because the operating performance of such reporting segments is evaluated. It connects farmers to consumers to deliver essential and sustainable food, feed and fuel. The company was founded on February 14, 2023 and is headquartered in Chesterfield, MO.

Bunge Global SA

Tariff Cuts Are The ‘Single Most Possible Deliverable’ From Trump-Xi Talks, Says Jefferies: AI Chips, Rare Earths Relief Unlikely

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Jefferies called the proposed Board of Trade the “single most possible deliverable,” potentially opening the door to broader tariff reductions.</li><li>The firm added that Boeing and medical-device makers could benefit from renewed trade commitments.</li><li>It said agricultural and U.S. energy exporters could also see support.</li></ul>President Donald Trump and Chinese President Xi Jinping are set to meet Thursday, but Jefferies analysts said investors should not expect the talks to resolve two major market overhangs – AI chip export controls and rare-earth supplies.In a note to investors cited by Barrons, Jefferies said the “single most possible deliverable” from Thursday’s talks is the Trump administration’s plan for a Board of Trade to oversee reduced tariffs across a range of goods.The framework would extend the tariff-cutting approach the two countries have used since their meeting in Busan last October, when Trump reduced tariffs on Chinese imports to 47% from 57% in exchange for eased rare-earth restrictions and resumed soybean purchases.The meeting, Xi's first Washington visit in a decade, caps a week of preparatory talks between Treasury Secretary Scott Bessent, U.S. Trade Representative Jamieson Greer, and their Chinese counterparts covering trade, AI, and critical minerals.&nbsp;<h2 class="st-heading-2">Who Could Benefit From Trump-Xi Meeting?</h2>Jefferies flagged Boeing (BA) and medical-device makers as potential beneficiaries, pointing to recent comments from Greer as encouraging.&nbsp;<a href="https://stocktwits.com/symbol/BA">BA stock</a> edged 0.25% higher in pre-market trade on Wednesday. On Stocktwits, retail sentiment around the airplane manufacturer trended in ‘bullish’ territory over the past day.China had previously pledged to buy more than 200 Boeing aircraft and increase U.S. agricultural purchases by $17 billion annually under the May framework. Agricultural companies tied to soybean exports, including Archer-Daniels-Midland (ADM) and Bunge (BG), along with U.S. energy exporters, could also benefit if those commitments are reaffirmed.<a href="https://stocktwits.com/symbol/ADM">ADM stock</a> and&nbsp;<a href="https://stocktwits.com/symbol/BG">BG stock</a> edged around 0.20% higher in pre-market trade, while retail sentiment around both of them trended in ‘neutral’ territory over the past day.<h2 class="st-heading-2">AI Chips And Rare Earths Remain Off The Table</h2>Jefferies does not expect Thursday’s meeting to produce meaningful movement on semiconductors or rare earths, which remain closely tied to national-security concerns in both countries.That leaves chipmakers with significant China exposure, including Nvidia (NVDA), AMD (AMD) and Qualcomm (QCOM), without an expected catalyst from the talks. Rare-earth producer MP Materials (MP) is similarly outside Jefferies’ expected list of beneficiaries.<a href="https://stocktwits.com/symbol/NVDA">NVDA stock</a> traded flat in pre-market trade, while&nbsp;<a href="https://stocktwits.com/symbol/QCOM">QCOM</a> and&nbsp;<a href="https://stocktwits.com/symbol/AMD">AMD shares</a> edged 0.40% lower.&nbsp;<a href="https://stocktwits.com/symbol/MP">MP stock</a> edged around 0.12% higher.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-un-speech-us-president-signals-potential-iran-deal-after-midterms/cZMPrnJRBey">Trump UN Speech: US President Signals Potential Iran Deal After Midterms, But Also Urges Nations For Tehran’s Complete Economic Isolation</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chinese President Xi Jinping and U.S. President Donald Trump attend a welcoming ceremony

The meeting is Chinese President Xi Jinping's first Washington visit in a decade and caps a week of preparatory talks.

Trump-Xi Talks May Bring Tariff Cuts, But AI Chips And Rare Earths Stay Off Table, Says Jefferies

The meeting is Chinese President Xi Jinping's first Washington visit in a decade and caps a week of preparatory talks. 

Advanced Micro Devices Inc

Boeing Co

MP Materials Corporation

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$3.19	--	--	N/A
Q3 '26	$2.41	$2.56	6.12%	BEAT
Q2 '26	$1.97	$2.00	1.71%	BEAT
Q1 '26	$0.88	$1.83	107.26%	BEAT
Q4 '25	$1.81	$1.99	9.72%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

BG Earnings

Latest Earnings Results: Q3 '26

Historical Earnings